Englisch

Eligibility Acute Myeloid Leukemia NCT00322673

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of acute myeloid leukemia (except aml fab-m3 or acute promyelocytic leukemia [apl]) based on the world health organization (who) classification of ≥ 20% blasts in the bone marrow or peripheral blood at initial diagnosis (prior to start of standard chemotherapy)
Beschreibung

diagnosis of acute myeloid leukemia (except aml fab-m3 or acute promyelocytic leukemia [apl]) based on the world health organization (who) classification of ≥ 20% blasts in the bone marrow or peripheral blood at initial diagnosis (prior to start of standard chemotherapy)

Datentyp

boolean

Alias
UMLS CUI [1]
C0023467
UMLS CUI [2]
C1982687
UMLS CUI [3]
C0368761
ecog performance status of 0 or 1
Beschreibung

ecog performance status of 0 or 1

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.
Beschreibung

subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1518321
UMLS CUI [2,1]
C0023467
UMLS CUI [2,2]
C0277556
adequate liver and renal function
Beschreibung

adequate liver and renal function

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0232804
signed informed consent
Beschreibung

signed informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
anticancer therapy including chemotherapeutic, biologic, or investigative agents within 30 days of xl999 treatment
Beschreibung

anticancer therapy including chemotherapeutic, biologic, or investigative agents within 30 days of xl999 treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0920425
hematopoietic stem cell transplantation within the previous 6 weeks
Beschreibung

hematopoietic stem cell transplantation within the previous 6 weeks

Datentyp

boolean

Alias
UMLS CUI [1]
C1504389
immunosuppressive therapy (eg, cyclosporine, steroids, tacrolimus) for graft-versus-host disease (gvhd) within 30 days prior to the start of xl999
Beschreibung

immunosuppressive therapy (eg, cyclosporine, steroids, tacrolimus) for graft-versus-host disease (gvhd) within 30 days prior to the start of xl999

Datentyp

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0018133
the subject has not recovered to grade ≤ 1 or to within 10% of baseline from adverse events due to investigational or chemotherapeutic drugs or stem cell transplantation which were administered > 4 weeks prior to study enrollment
Beschreibung

the subject has not recovered to grade ≤ 1 or to within 10% of baseline from adverse events due to investigational or chemotherapeutic drugs or stem cell transplantation which were administered > 4 weeks prior to study enrollment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C2004454
uncontrolled and/or concomitant illness
Beschreibung

uncontrolled and/or concomitant illness

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
pregnant or breastfeeding females
Beschreibung

pregnant or breastfeeding females

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known hiv
Beschreibung

known hiv

Datentyp

boolean

Alias
UMLS CUI [1]
C0019682
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Acute Myeloid Leukemia NCT00322673

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
diagnosis of acute myeloid leukemia (except aml fab-m3 or acute promyelocytic leukemia [apl]) based on the world health organization (who) classification of ≥ 20% blasts in the bone marrow or peripheral blood at initial diagnosis (prior to start of standard chemotherapy)
boolean
C0023467 (UMLS CUI [1])
C1982687 (UMLS CUI [2])
C0368761 (UMLS CUI [3])
ecog
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.
Item
subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.
boolean
C0023467 (UMLS CUI [1,1])
C1518321 (UMLS CUI [1,2])
C0023467 (UMLS CUI [2,1])
C0277556 (UMLS CUI [2,2])
liver and renal function
Item
adequate liver and renal function
boolean
C0232741 (UMLS CUI [1,1])
C0232804 (UMLS CUI [1,2])
signed informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
anticancer therapy
Item
anticancer therapy including chemotherapeutic, biologic, or investigative agents within 30 days of xl999 treatment
boolean
C0920425 (UMLS CUI [1])
stem cell transplantation
Item
hematopoietic stem cell transplantation within the previous 6 weeks
boolean
C1504389 (UMLS CUI [1])
immunosuppressive therapy
Item
immunosuppressive therapy (eg, cyclosporine, steroids, tacrolimus) for graft-versus-host disease (gvhd) within 30 days prior to the start of xl999
boolean
C0021079 (UMLS CUI [1])
C0018133 (UMLS CUI [2])
adverse events recovery
Item
the subject has not recovered to grade ≤ 1 or to within 10% of baseline from adverse events due to investigational or chemotherapeutic drugs or stem cell transplantation which were administered > 4 weeks prior to study enrollment
boolean
C0877248 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
uncontrolled and/or concomitant illness
Item
uncontrolled and/or concomitant illness
boolean
C0009488 (UMLS CUI [1])
pregnant or breastfeeding females
Item
pregnant or breastfeeding females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
hiv
Item
known hiv
boolean
C0019682 (UMLS CUI [1])
Zum Seitenanfang zurückkehren